GSK plc Rightofuse Assets
GSK plc (GLAXF) had Rightofuse Assets of GBP 726.00 million as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-03-06
- 2025-12-31: Rightofuse Assets 726.00M GBP.
- 2024-12-31: Rightofuse Assets 846.00M GBP.
- 2023-12-31: Rightofuse Assets 937.00M GBP.
- 2022-12-31: Rightofuse Assets 687.00M GBP.
| Period end | Rightofuse Assets |
|---|---|
| 2025-12-31 | 726.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 846.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 937.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 687.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 740.00M GBP 20-F · filed 2023-03-10 |
| 2020-12-31 | 830.00M GBP 20-F · filed 2022-03-08 |
| 2019-12-31 | 966.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 1.07B GBP 20-F · filed 2021-03-12 |